Revolutionizing Regenerative Medicine for Hair Loss: Pelage Pharmaceuticals Secures $16.75M Series A Financing Led by GV
In a groundbreaking move poised to redefine the landscape of regenerative medicine for hair loss, Pelage Pharmaceuticals announces its successful closure of a Series A financing round, securing an impressive $16.75 million. Spearheaded by GV, this investment signals a resounding vote of confidence in Pelage’s innovative approach to addressing one of the most pervasive challenges […]